rss
Occup Environ Med doi:10.1136/oem.2008.041053

Use of Hair Coloring Products and Risk of Multiple Myeloma among U.S. Women

  1. Stella Koutros (koutross{at}mail.nih.gov)
  1. National Cancer Institute, National Institutes of Health, United States
    1. Dalsu Baris
    1. National Cancer Institute, National Institutes of Health, United States
      1. Erin Bell
      1. University at Albany, State University of New York, United States
        1. Tongzhang Zheng
        1. Yale University, School of Medicine, United States
          1. Yawei Zheng
          1. Yale University, School of Medicine, United States
            1. Theodore R Holford
            1. Yale University, School of Medicine, United States
              1. Brian P Leaderer
              1. Yale University, School of Medicine, United States
                1. Ola Landgren
                1. National Cancer Institute, National Institutes of Health, United States
                  1. Shelia Hoar Zahm
                  1. National Cancer Institute, National Institutes of Health, United States
                    • Published Online First 19 September 2008

                    Abstract

                    Objective: To evaluate the association between personal hair dye use and risk of multiple myeloma among women.

                    Methods: We conducted a population-based case-control study to identify 175 cases of multiple myeloma and 679 controls. Cases and controls were interviewed in-person by trained interviewers regarding their use of hair coloring products. Subjects were asked to report the type and color of the hair coloring product used, age at first use, age use stopped, duration, and the frequency of use per year. Odds ratios (ORs) and 95% confidence intervals (CI) were estimated using unconditional logistic regression to compare never users with four exposure groups: all users, ever semi-permanent users, ever permanent users, and dark permanent users (most frequent use).

                    Results: We did not find any association between ever reporting hair coloring product use and myeloma risk among all users: OR=0.8, 95% CI=0.5-1.1, semi-permanent users: OR=0.7, 95% CI=0.4-1.2, permanent users: OR=0.8, 95% CI=0.5-1.1, or dark permanent users: OR=0.8, 95% CI=0.5-1.3. There were no significant associations among women who used hair dyes before 30 years of age, who started use before 1980, who had ¡Ý240 lifetime applications, or for dark permanent users with 28 or more years of use.

                    Conclusion: We did not find any evidence of an association between hair coloring product use and myeloma risk. However, given the conflicting body of literature on hair coloring product use and risk of multiple myeloma, this question should be further evaluated in larger studies or consortia, and in high risk groups.

                    This Article

                    1. All Versions of this Article:
                      1. oem.2008.041053v1
                      2. 66/1/68 most recent

                    Services

                    1. Request permissions

                    Responses

                    1. Submit a response
                    2. No responses published

                    Social bookmarking

                    Register for free content


                    Free sample
                    This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of OEM.
                    View free sample issue >>

                    Free archive
                    The full back archive is now available for OEM. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
                    Register to access the free archive >>

                    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.